Variant report
Variant | nsv1025440 |
---|---|
Chromosome Location | chr9:26555201-26572236 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73642955 | chr9:26561207-26561208 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs537341079 | chr9:26561279-26561280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs377750128 | chr9:26561291-26561292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537985124 | chr9:26561298-26561299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs138521117 | chr9:26561320-26561321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568033881 | chr9:26561328-26561329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534839842 | chr9:26561344-26561345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373151670 | chr9:26561375-26561376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113918165 | chr9:26561389-26561390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376447452 | chr9:26561404-26561405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7847137 | chr9:26561413-26561414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538601738 | chr9:26561417-26561418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557242426 | chr9:26561437-26561438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141882654 | chr9:26561438-26561439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187868048 | chr9:26561442-26561443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561353839 | chr9:26561485-26561486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573373027 | chr9:26561595-26561596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541147182 | chr9:26561601-26561602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577994811 | chr9:26561621-26561622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116458363 | chr9:26561635-26561636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551434969 | chr9:26561643-26561644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7861196 | chr9:26561661-26561662 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs116230465 | chr9:26561703-26561704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549243802 | chr9:26561781-26561782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs192915055 | chr9:26561807-26561808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs35466923 | chr9:26561823-26561824 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs1887222 | chr9:26561828-26561829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs113332824 | chr9:26561847-26561848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs62544457 | chr9:26561866-26561867 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs538739561 | chr9:26561919-26561920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144586553 | chr9:26561960-26561961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188809617 | chr9:26561992-26561993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs148459587 | chr9:26561996-26561997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555213586 | chr9:26562005-26562006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs75836978 | chr9:26562029-26562030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12335551 | chr9:26562049-26562050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565467906 | chr9:26562068-26562069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs62544458 | chr9:26562070-26562071 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs62544459 | chr9:26562077-26562078 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs563170216 | chr9:26562098-26562099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530491024 | chr9:26562288-26562289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs549029232 | chr9:26562307-26562308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561190758 | chr9:26562329-26562330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs73642956 | chr9:26562349-26562350 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs554056564 | chr9:26562376-26562377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571109272 | chr9:26562380-26562381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538778805 | chr9:26562410-26562411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs551040503 | chr9:26562431-26562432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs76340190 | chr9:26562466-26562467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536598755 | chr9:26562491-26562492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21858162 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
polycythaemia | 22829968 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21364760 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:26561200-26564000 | Enhancers | Hela-S3 | cervix |
2 | chr9:26561600-26562800 | Enhancers | Fetal Lung | lung |
3 | chr9:26562000-26562400 | Enhancers | HepG2 | liver |
4 | chr9:26564000-26564400 | Weak transcription | Hela-S3 | cervix |
5 | chr9:26564400-26564800 | Enhancers | Hela-S3 | cervix |
6 | chr9:26565000-26565400 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
7 | chr9:26565600-26566000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr9:26566200-26566600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
9 | chr9:26566200-26566600 | Enhancers | Fetal Muscle Leg | muscle |
10 | chr9:26566200-26566600 | Enhancers | Psoas Muscle | Psoas |
11 | chr9:26567600-26568000 | Enhancers | Skeletal Muscle Female | skeletal muscle |